Micellae’s powder platform is based on the process of solidification of the O2W liquid platform in which fine liquid droplets are microencapsulated to combine the advantages of the conventional liquid SMEDDSs with those of the solid dosage forms. Microencapsulation is the process of coating one or more active ingredients with a (mixture of) polymer(s), forming a shell, with the objective of providing a physical barrier between the active ingredient and other components of the product to protect it from environmental factors like humidity, light, and air. In a simplistic form, a microcapsule is a small sphere with an inner core containing one or more active compounds covered with a coating material sometimes called shell, membrane, coat, or wall. The coating materials are usually polymers from natural or synthetic sources, selected depending on the compound to be coated, the characteristics desired in the final capsules, and the type of release required. Depending on the coating material, many triggers can be used to activate the release of the encapsulated compounds: temperature, pH change (enteric and anti-enteric coating), enzymatic activity, time, etc. While the conventional microencapsulation process involves coating the active ingredients, Micellae’s microcapsule coats the droplets of the CBD-loaded liquid delivery system.